募投项目效益

Search documents
广大特材(688186.SH)发预增,预计前三季度归母净利润约2.48亿元,同比增约213.92%
智通财经网· 2025-10-09 10:34
报告期内,公司下游所属行业需求整体向好,营销部门积极拓展客户订单,公司合力保交付,营业收入 同比实现增长25.04%左右。报告期内,公司根据市场变化情况适时优化内部产品结构,同时采取了一 系列降本增效措施,使得整体毛利率得到较好的修复,公司盈利能力得以增强。此外,募投项目效益显 现:其中,风电齿轮箱零部件项目产能逐步释放,机加工设备平均利用率大幅度提升,加工产值给予公 司较大贡献,并因产能释放而有效降低单位固定成本,实现盈利。海上风电铸件项目通过一系列技术改 造、产线优化、工艺降本、产品多样化等方式促使产能利用率大幅度提升,熔炼产能满负荷运转,实现 盈利。 智通财经APP讯,广大特材(688186.SH)发布公告,公司预计2025年前三季度实现归属于母公司所有者 的净利润为2.48亿元左右,与上年同期(法定披露数据)相比,预计增加1.69亿元左右,同比增加213.92% 左右。 ...
广大特材(688186.SH):前三季度净利润同比预增213.92%左右
Ge Long Hui A P P· 2025-10-09 09:41
格隆汇10月9日丨广大特材(688186.SH)公布,经财务部门初步测算,预计2025年前三季度实现营业收入 为37.00亿元左右,与上年同期(法定披露数据)相比,将增加7.41亿元左右,同比增加25.04%左右。 预计2025年前三季度实现归属于母公司所有者的扣除非经常性损益的净利润为2.40亿元左右,与上年同 期(法定披露数据)相比,预计增加1.97亿元左右,同比增加458.14%左右。 报告期内,公司根据市场变化情况适时优化内部产品结构,同时采取了一系列降本增效措施,使得整体 毛利率得到较好的修复,公司盈利能力得以增强。募投项目效益显现:其中,风电齿轮箱零部件项目产 能逐步释放,机加工设备平均利用率大幅度提升,加工产值给予公司较大贡献,并因产能释放而有效降 低单位固定成本,实现盈利。海上风电铸件项目通过一系列技术改造、产线优化、工艺降本、产品多样 化等方式促使产能利用率大幅度提升,熔炼产能满负荷运转,实现盈利。 预计2025年前三季度实现归属于母公司所有者的净利润为2.48亿元左右,与上年同期(法定披露数据) 相比,预计增加1.69亿元左右,同比增加213.92%左右。 ...
广东嘉元科技股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-25 20:04
Core Viewpoint - The company, Guangdong Jiayuan Technology Co., Ltd., is set to hold a performance briefing on September 3, 2025, to discuss its half-year results and financial status, inviting investor participation and questions [3][4][5]. Group 1: Company Overview - The company is listed under the stock code 688388 and is involved in the new energy sector [1]. - The company has not made any significant changes to its governance structure or shareholder arrangements during the reporting period [1][2]. Group 2: Financial Data - The company reported a total fundraising amount of RMB 1,240 million from convertible bonds issued in 2021, with a net amount of RMB 1,225 million after deducting issuance costs [21]. - The company raised RMB 3,407 million from a private placement of shares, with a net amount of RMB 3,378 million after costs [22]. - As of June 30, 2025, the company had unutilized fundraising balances of RMB 113 million from convertible bonds and RMB 253 million from the private placement [23][24]. Group 3: Fund Management - The company has established a fundraising management system to ensure efficient use and protection of investor rights [25][26]. - The company has signed tripartite supervision agreements for the management of fundraising accounts with various banks [27]. - As of June 30, 2025, the company had no idle funds from the convertible bonds and had RMB 230 million in cash management from the private placement [31][33]. Group 4: Performance Briefing Details - The performance briefing will take place online at the Shanghai Stock Exchange Roadshow Center, allowing for interactive Q&A [5][7]. - Key executives, including the chairman and financial officer, will participate in the briefing [5][14].
思泉新材: 致同会计师事务所(特殊普通合伙)关于广东思泉新材料股份有限公司前次募集资金使用情况鉴证报告
Zheng Quan Zhi Xing· 2025-07-31 16:26
| 广东思泉新材料股份有限公司 | | | --- | --- | | 前次募集资金使用情况 | | | 鉴证报告 | | | 致同会计师事务所(特殊普通合伙) | | | 目 录 | | | 前次募集资金使用情况鉴证报告 1-2 | | | 公司前次募集资金使用情况报告 1-5 | | | 前次募集资金使用情况对照表 6 | | | 前次募集资金投资项目实现效益情况对照表 7 | | | 致同会计师事务所(特殊普通合伙) | | | 中国北京朝阳区建国门外大街 22 号 | | | 5 层邮编 100004 赛特广场 | | | 电话 +86 10 8566 5588 | | | +86 10 8566 5120 | | | 传真 | | | www.grantthornton.cn | | | 前次募集资金使用情况鉴证报告 | | | 致同专字(2025)第 441A017921 号 | | | 广东思泉新材料股份有限公司全体股东: | | | 我们审核了后附的广东思泉新材料股份有限公司(以下简称思泉新材)截 | | | 至 2025 年 6 月 30 日的前次募集资金使用情况报告、前次募集资金使用情况对 ...
华康股份: 华康股份关于上海证券交易所对公司2024年年度报告的信息披露监管问询函的回复公告
Zheng Quan Zhi Xing· 2025-05-26 11:17
Core Viewpoint - Zhejiang Huakang Pharmaceutical Co., Ltd. received an inquiry letter from the Shanghai Stock Exchange regarding its 2024 annual report, prompting the company to clarify issues related to its construction projects and investment performance, particularly concerning the erythritol production project which has underperformed financially due to market conditions [1][2]. Summary by Sections Construction Projects and Investment - In 2024, the company invested 1.43 billion yuan in fixed assets, intangible assets, and other long-term assets, marking a 106.99% increase year-on-year. The fixed assets reached 2.25 billion yuan, up 45.13%, while construction in progress surged by 357.58% to 1.33 billion yuan, primarily due to the Zhoushan Huakang project [1]. - The erythritol production project generated revenue of 72.44 million yuan in 2024 but incurred a gross loss of 1.72 million yuan, continuing to fall short of initial projections since its trial operation began in May 2022 [1][2]. Erythritol Project Details - The total investment for the erythritol project is estimated at 350.41 million yuan, with cumulative investment reaching 362.68 million yuan by the end of 2024. The project aims to produce 30,000 tons of high-purity erythritol annually [5][6]. - In 2024, the company produced 6,834.50 tons of erythritol, achieving a sales rate of 97.96%. The market price for erythritol was approximately 13,000 yuan per ton by December 2024 [6][11]. Market Conditions and Competition - The erythritol market has faced significant challenges, including declining prices and increased competition, leading to a supply-demand imbalance. The price of erythritol has been under pressure since 2023, with some manufacturers exiting the market [7][11]. - The company noted that the market for erythritol was initially promising, but the influx of new competitors and expanded capacities led to a significant drop in prices, affecting profitability [7][11]. Inventory and Trade Business - By the end of 2024, the company's inventory reached 697 million yuan, a 147.26% increase year-on-year, primarily due to increased raw material reserves for the Zhoushan project. The raw materials accounted for 448 million yuan, up 385.15% [15][16]. - The cash flow from trade business payments was 1.15 billion yuan, reflecting a 198.58% increase, driven by the anticipated demand for corn from the Zhoushan project [15][16].